IRadimed Corporation
IRMD
$69.57
-$1.12-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.61% | 0.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.61% | 0.63% | |||
| Cost of Revenue | -4.57% | 0.85% | |||
| Gross Profit | 7.49% | 0.55% | |||
| SG&A Expenses | -5.66% | 4.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.25% | 3.61% | |||
| Operating Income | 24.97% | -6.36% | |||
| Income Before Tax | 23.24% | -6.29% | |||
| Income Tax Expenses | 23.47% | 5.04% | |||
| Earnings from Continuing Operations | 23.18% | -8.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.18% | -8.93% | |||
| EBIT | 24.97% | -6.36% | |||
| EBITDA | 24.35% | -6.16% | |||
| EPS Basic | 23.16% | -9.14% | |||
| Normalized Basic EPS | 23.20% | -6.55% | |||
| EPS Diluted | 22.05% | -8.05% | |||
| Normalized Diluted EPS | 23.16% | -6.46% | |||
| Average Basic Shares Outstanding | 0.01% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.12% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.19% | 0.25% | |||